Metrics From Wearable Devices Can Predict IBD Flares
FRIDAY, Jan. 24, 2025 -- Physiological metrics from wearable devices can help identify inflammatory bowel disease (IBD) flares, according to a study published online Jan. 16 in Gastroenterology.
Robert P. Hirten, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the predictive abilities of physiological metrics, measured using wearable devices in patients with IBD. A total of 309 patients were enrolled across 36 states.
The researchers found significant differences in circadian patterns of heart rate variability between periods of inflammatory flare and remission and between symptomatic flare and remission. During periods of inflammatory flare and symptomatic flare, marginal means for longitudinal heart rate and resting heart rate were higher. During inflammatory flares, lower daily steps were recorded. Heart rate variability, heart rate, and resting heart rate could establish the presence of inflammation among patients with symptoms. Up to seven weeks prior to inflammatory and symptomatic flares, heart rate variability, heart rate, resting heart rate, steps, and oxygenation were significantly altered.
"These findings open the door to leveraging wearable technology for health monitoring and disease management in innovative ways we haven't previously considered," Hirten said in a statement. "Our hope is that, in the future, this approach will significantly enhance the quality of life of our patients."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.